ClinicalTrials.gg
RecruitingNCT07522177Updated Oct 29, 2026

Animated Storytelling to Promote Colorectal Cancer Screening

An interventional study of Short animated storytelling video in Colorectal Cancer Screening, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Stanford University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 29, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,000
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Colorectal Neoplasms by Stanford University — 3 open to participants now, 3 under way, none of them phase 3. Colorectal Neoplasms · Stanford University.

Planned enrollment
2nd of 10
3,000 · median 60
Started
2026
with 1 other
No phase
8 of 13
3 open now
Registered
13th of 13
by date

Among the 13 studies in Colorectal Neoplasms by Stanford University, this one is the 2nd largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 8 with no phase, and was the 13th registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

3 of the 13 studies in Colorectal Neoplasms by Stanford University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Colorectal Neoplasms by Stanford University, or all of them as a file.
02

Study summary

This online randomized controlled trial will evaluate whether a short animated storytelling video increases behavioral expectation to obtain colorectal cancer screening among screening-eligible U.S. adults who report not yet having completed screening. Participants will be recruited via Prolific and randomized in Stanford Qualtrics to view either a brief animated video or a time-neutral informational text. Outcomes will be assessed immediately after exposure.

03

Conditions studied

  • Colorectal Cancer Screening
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Resides in the United States
  • Able to read and understand English
  • Self-reports not having completed colorectal cancer screening
  • Provides electronic

Exclusion criteria

Exclusion Criteria:

  • Prior diagnosis of colorectal cancer
  • Self-reported completion of colorectal cancer screening
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,000 participants (estimated)

Study arms

  • Experimental
    Animated Storytelling Video

    Participants view a brief animated storytelling video about colorectal cancer screening and colonoscopy.

    Behavioral: Short animated storytelling video

  • No intervention
    Do-nothing Control

    Participants complete surveys only and receive no intervention.

Interventions

  • BehavioralShort animated storytelling video

    A brief animated storytelling video about colorectal cancer screening and colonoscopy.

06

What researchers measure

Primary outcomes

  1. Change from baseline in behavioral expectation (simple and next-step) to obtain colorectal cancer screening, as measured by a 7-item visual analogue scale.

    Participant self-reports their likelihood of discussing, scheduling, or obtaining colorectal cancer screening after exposure to assigned study material. Total scores range from 0-70 with higher scores indicating greater behavioral expectation (Item 7 is reverse scored).

    Time frame: Baseline, immediately post-intervention exposure (up to 24 hours)

Secondary outcomes

  1. Change from baseline in knowledge about colorectal cancer screening and colonoscopy, as measured by a 5-item knowledge questionnaire.

    Self-reported knowledge regarding colorectal cancer screening and the preventive role of colonoscopy, including detection and removal of pre-cancerous polyps. Response options are true/false/not sure, with 1 point per correct answer and 0 points for incorrect or "not sure". Total scores range from 0-5, with higher scores indicating higher knowledge.

    Time frame: Baseline, immediately post-intervention exposure (up to 24 hours)

  2. Change from baseline in perceptions and beliefs about colonoscopy, as measured by a 13-item scale.

    Self-reported perceptions an beliefs about colonoscopy include perceived susceptibility, perceived severity, perceived benefits and perceived barriers. Responses will be compared on a Likert scale that ranges from 1-5 (Strongly disagree / Disagree / Neither / Agree / Strongly agree), where higher scores indicate more positive perceptions and beliefs, with the perceived barriers section reverse scored.

    Time frame: Baseline, immediately post-intervention exposure (up to 24 hours)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Nov 2026, 1 month after the start.

Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 1 month is below that.

Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 29, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2026
First posted
Apr 13, 2026
StartActual
Oct 16, 2026was Sep 2026
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 29, 2026
Sites
Stanford University is now Recruiting
Oct 29, 2026
Start date
Sep 2026→Oct 16, 2026 (actual)
Oct 29, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Stanford University · Stanford, United StatesContact added m•••@stanford.edu · •••3600
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Not yet recruiting→Recruiting
    Stanford University is now Recruiting
    Start date Sep 2026→Oct 16, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Stanford University · Stanford, United StatesContact added m•••@stanford.edu · •••3600
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07522177
Responsible party
Maya Adam (Clinical Associate Professor of Pediatrics, Stanford University) — Principal investigator
First posted
Apr 13, 2026
Start date
Oct 16, 2026
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 29, 2026

Study contacts

Maya Adam, MD, PhD
principal investigator · Stanford University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion